ES2067624T3 - Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal. - Google Patents

Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.

Info

Publication number
ES2067624T3
ES2067624T3 ES90120880T ES90120880T ES2067624T3 ES 2067624 T3 ES2067624 T3 ES 2067624T3 ES 90120880 T ES90120880 T ES 90120880T ES 90120880 T ES90120880 T ES 90120880T ES 2067624 T3 ES2067624 T3 ES 2067624T3
Authority
ES
Spain
Prior art keywords
nasal administration
preparing
procedure
pharmaceutical composition
liquid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90120880T
Other languages
English (en)
Inventor
Giancarlo Ceschel
Antonella Maria Segu
Celestino Ronchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ph & T Srl
Original Assignee
Ph & T Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT8922398A external-priority patent/IT8922398A0/it
Priority claimed from IT02094690A external-priority patent/IT1243343B/it
Application filed by Ph & T Srl filed Critical Ph & T Srl
Application granted granted Critical
Publication of ES2067624T3 publication Critical patent/ES2067624T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICION LIQUIDA PARA ADMINISTRACION NASAL DE POLIPEPTIDOS QUE CONTIENE TARTRATO DE AMONIO Y UN AMORTIGUADOR CON AUXILIARES OPCIONALES.
ES90120880T 1989-11-16 1990-10-31 Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal. Expired - Lifetime ES2067624T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8922398A IT8922398A0 (it) 1989-11-16 1989-11-16 Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.
IT02094690A IT1243343B (it) 1990-07-16 1990-07-16 Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva

Publications (1)

Publication Number Publication Date
ES2067624T3 true ES2067624T3 (es) 1995-04-01

Family

ID=26327710

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90120880T Expired - Lifetime ES2067624T3 (es) 1989-11-16 1990-10-31 Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.

Country Status (4)

Country Link
US (1) US5124315A (es)
EP (1) EP0432431B1 (es)
DE (1) DE69001991T2 (es)
ES (1) ES2067624T3 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
DK0708657T3 (da) * 1993-06-29 2001-10-15 Ferring Bv Sammensætninger til nasal administration af desmopression
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
US6187332B1 (en) * 1999-06-14 2001-02-13 Wisconsin Alumni Research Foundation Acidic buffered nasal spray
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
WO2004084859A2 (en) 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS57130961A (en) * 1981-02-04 1982-08-13 Seiwa Kasei:Kk Polypeptide derived from quaternary trimethylammonium
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US4466960A (en) * 1983-10-18 1984-08-21 Thompson Medical Co., Inc. Analgesic-diuretic compositions
US4658830A (en) * 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
ATE60999T1 (de) * 1986-12-19 1991-03-15 Duphar Int Res Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.
IT1222395B (it) * 1987-07-30 1990-09-05 Pierrel Spa Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
IT1223132B (it) * 1987-11-13 1990-09-12 Isf Spa Composizione farmaceutica per somministrazione nasale
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
US5015626A (en) * 1989-08-02 1991-05-14 Iowa State University Research Foundation, Inc. Porcine somatotropin to improve meat quality of pigs
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration

Also Published As

Publication number Publication date
DE69001991D1 (de) 1993-07-22
US5124315A (en) 1992-06-23
EP0432431B1 (en) 1993-06-16
DE69001991T2 (de) 1993-09-23
EP0432431A1 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
ES2067624T3 (es) Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.
DK164408C (da) Vaeksthormonfrigivende faktorforbindelser, forbindelserne til anvendelse som terapeutikum, fremgangsmaade til fremstilling af forbindelserne, farmaceutiske praeparater, der indeholder en effektiv maengde af en saadan forbindelse samt anvendelse af forbindelsen
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
IL61375A (en) 4-amino-2-(cyclic amino)-6-chloro-7-alkoxy-quinazoline derivatives,pharmaceutical compositions containing them and the corresponding 2-chlorointermediates therefor
PT84354B (pt) Dispositivo para aplicacao de suspensoes de medicamentos
DK407588D0 (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse
DK52189A (da) Farmaceutisk praeparat indeholdende igf i samt fremgangsmaade til fremstilling deraf
GB8319513D0 (en) Needleless hypodermic injector
ES8802055A1 (es) Procedimiento para la fabricacion de derivados gangliosidos
ES468317A1 (es) Perfeccionamientos introducidos en una capsula de cierre llena de material viscoso, en particular de un preparado farma-ceutico liquido.
ES537022A0 (es) Un procedimiento para la preparacion de una formulacion medicamentosa para inyeccion intravenosa.
DK166149C (da) Antipsykotiske 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivater, farmaceutiske praeparater indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
ES2035086T3 (es) Procedimiento para preparar una composicion solida y estable que contiene ibuprofeno y codeina.
ES539500A0 (es) Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas
MX9205155A (es) Derivados heterociclicos n-substituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK642588D0 (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK592189A (da) Nitroimidazoler, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK469189D0 (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
IT8648547A0 (it) Derivati di dicloroanilina,procedimento per prepararli e composizioni farmaceutiche che li contengono
IT8448124A0 (it) Capsula a sigillo di garanzia, in particolare per flaconi per uso farmaceutico
DK221288D0 (da) 2beta-,16beta-diamino-androstaner og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende en saadan forbindelse
ATE139701T1 (de) Zusammensetzung zur herabsetzung der nebenwirkungen eines arzneimittels
MX7715E (es) Procedimiento para la preparacion de una composicion farmaceutica a base de microgranulos que contiene sulpirida
DK176183D0 (da) Beta-lactam-antibiotika, fremgangsmade til fremstilling deraf samt deres anvendelse som laegemiddel
JO1120B1 (en) N- (1-night-2-pyrrolidinyl-methyl) 2-methoxy-4-amino-5-methylsulfamoyil benzamide, method of preparation and use as a drug

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 432431

Country of ref document: ES